The PE ratio for Encompass Health stock stands at 23.22 as of Feb 21, 2025. This results from the current EPS of $4.2 and stock price of $97.53. An increase of 8% has been seen in the P/E ratio compared to the average of 21.4 of the last 4 quarters.
Over the last ten years, the average PE ratio of Encompass Health has been 19.52. The current 23.22 PE ratio is 19% above the historical average. Over the past ten years, EHC's PE ratio was at its highest in the Dec 2020 quarter at 28.81, with a price of $82.69 and an EPS of $2.87. The Mar 2017 quarter recorded the bottom point at 14.86, with a price of $42.81 and an EPS of $2.88.
Maximum annual increase: 507.98% in 2009
Maximum annual decrease: -90.98% in 2010
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
2023 | 19.01 | -13.55% | $66.72 | $3.51 |
2022 | 21.99 | 39.8% | $59.81 | $2.72 |
2021 | 15.73 | -45.4% | $65.26 | $4.15 |
2020 | 28.81 | 51.79% | $82.69 | $2.87 |
2019 | 18.98 | -8.31% | $69.27 | $3.65 |
2018 | 20.7 | 20.63% | $61.7 | $2.98 |
2017 | 17.16 | 15.25% | $49.41 | $2.88 |
2016 | 14.89 | -13.58% | $41.24 | $2.77 |
2015 | 17.23 | 10.24% | $34.81 | $2.02 |
2014 | 15.63 | 21.07% | $38.46 | $2.46 |
2013 | 12.91 | 2.14% | $33.32 | $2.58 |
2012 | 12.64 | 36.65% | $21.11 | $1.67 |
2011 | 9.25 | 320.45% | $17.67 | $1.91 |
2010 | 2.2 | -90.98% | $20.71 | $9.41 |
2009 | 24.38 | 507.98% | $18.77 | $0.77 |
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
Sep 2024 | 23.01 | 6.48% | $96.64 | $4.2 |
Jun 2024 | 21.61 | -1.86% | $85.79 | $3.97 |
Mar 2024 | 22.02 | 15.83% | $82.58 | $3.75 |
Dec 2023 | 19.01 | 0.21% | $66.72 | $3.51 |
Sep 2023 | 18.97 | -12.01% | $67.16 | $3.54 |
Jun 2023 | 21.56 | 8.4% | $67.71 | $3.14 |
Mar 2023 | 19.89 | -9.55% | $54.1 | $2.72 |
Dec 2022 | 21.99 | 33.68% | $59.81 | $2.72 |
Sep 2022 | 16.45 | -3.12% | $45.23 | $2.75 |
Jun 2022 | 16.98 | -5.67% | $56.05 | $3.3 |
Mar 2022 | 18 | 14.43% | $71.11 | $3.95 |
Dec 2021 | 15.73 | -14.46% | $65.26 | $4.15 |
Sep 2021 | 18.39 | -9.05% | $75.04 | $4.08 |
Jun 2021 | 20.22 | -24.44% | $78.03 | $3.86 |
Mar 2021 | 26.76 | -7.12% | $81.9 | $3.06 |
EHC's current P/E ratio is above the 3, 5 and 10-year historical averages.
EHC's PE ratio is higher than its peer stock SEM.
Stock name | PE ratio | Market cap |
---|---|---|
SEM Select Medical Holdings Corp | 10.65 | $2.28B |
EHC Encompass Health Corp | 23.22 | $9.83B |
NUTX Nutex Health Inc | N/A | $313.17M |
As of Feb 21, 2025, EHC stock has a price to earnings ratio of 23.22.
The average PE ratio for EHC stock over the past 3 years is 19.95.
The average PE ratio for EHC stock over the past 5 years is 20.7.
In the last ten years, the Dec 2020 quarter recorded the highest quarterly PE ratio at 28.81.
EHC's price to earnings ratio is currently 19% above its 10-year historical average.
The PE ratio is calculated by dividing the most recent price of a stock by its trailing twelve months EPS. As of today (Feb 21, 2025), Encompass Health's stock price is $97.53. The earnings per share for the trailing twelve months (TTM) ending Sep 2024 is $4.2. Therefore, Encompass Health's P/E ratio for today is 23.22. PE RATIO(23.22) = STOCK PRICE($97.53) / TTM EPS($4.2)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.